反応式
[CH3:1][CH:2]([C:16]([OH:18])=[O:17])[C:3]1[CH:4]=[CH:5][C:6]([C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=2)=[C:7]([F:9])[CH:8]=1.[N:19]1[CH:24]=[CH:23][C:22](/[CH:25]=[CH:26]/[C:27]2[CH:32]=[CH:31][N:30]=[CH:29][CH:28]=2)=[CH:21][CH:20]=1>CC(C)=O>[CH3:1][CH:2]([C:16]([OH:18])=[O:17])[C:3]1[CH:4]=[CH:5][C:6]([C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)=[C:7]([F:9])[CH:8]=1.[N:19]1[CH:24]=[CH:23][C:22]([CH:25]=[CH:26][C:27]2[CH:28]=[CH:29][N:30]=[CH:31][CH:32]=2)=[CH:21][CH:20]=1参加物
4
実験手順
25 mg (0.1023 mmol) flurbiprofen and 10 mg (0.0548 mmol) trans-1,2-bis(4-pyridyl) ethylene were dissolved in 3 mL acetone. Slow evaporation of the solvent yielded colorless needles of a 2:1 flurbiprofen/1,2-bis(4-pyridyl) ethylene co-crystal, as shown in FIG. 49A-B.
後処理
- customevaporation of the solvent
出典と根拠
- ORDレコード
- ord-d3341fbd05d24c95bf6336bcec8e3b17
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07927613B2
関連ノート
読み込み中…